-
Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
Vahabi, M., Xu, G., Avan, A., Peters, G. J. & Giovannetti, E., 2024, (E-pub ahead of print) In: Nucleosides, Nucleotides and Nucleic Acids.Research output: Contribution to journal › Article › Academic › peer-review
-
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Carbone, D., Pecoraro, C., Panzeca, G., Xu, G., Roeten, M. S. F., Cascioferro, S., Giovannetti, E., Diana, P. & Parrino, B., 1 Jul 2023, In: Marine Drugs. 21, 7, 412.Research output: Contribution to journal › Article › Academic › peer-review
-
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Capula, M., Perán, M., Xu, G., Donati, V., Yee, D., Gregori, A., Assaraf, Y. G., Giovannetti, E. & Deng, D., 1 Sept 2022, In: Drug resistance updates. 64, p. 1-16 16 p., 100864.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
